These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38649638)
1. Detection of CRISPR/Cas9-Mediated Fetal Hemoglobin Reactivation in Erythroblasts Derived from Cord Blood-Hematopoietic Stem Cells. Maroofi N; Maleki MSM; Tahmasebi M; Khorshid HRK; Modaberi Y; Najafipour R; Banan M Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38649638 [TBL] [Abstract][Full Text] [Related]
2. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements. Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953 [TBL] [Abstract][Full Text] [Related]
3. Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major. Psatha N; Reik A; Phelps S; Zhou Y; Dalas D; Yannaki E; Levasseur DN; Urnov FD; Holmes MC; Papayannopoulou T Mol Ther Methods Clin Dev; 2018 Sep; 10():313-326. PubMed ID: 30182035 [TBL] [Abstract][Full Text] [Related]
4. Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34 Katta V; O'Keefe K; Li Y; Mayuranathan T; Lazzarotto CR; Wood RK; Levine RM; Powers A; Mayberry K; Manquen G; Yao Y; Zhang J; Jang Y; Nimmagadda N; Dempsey EA; Lee G; Uchida N; Cheng Y; Fazio F; Lockey T; Meagher M; Sharma A; Tisdale JF; Zhou S; Yen JS; Weiss MJ; Tsai SQ Mol Ther; 2024 Oct; 32(10):3433-3452. PubMed ID: 39086133 [TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Engraftment and Fetal Globin Induction upon Chang KH; Smith SE; Sullivan T; Chen K; Zhou Q; West JA; Liu M; Liu Y; Vieira BF; Sun C; Hong VP; Zhang M; Yang X; Reik A; Urnov FD; Rebar EJ; Holmes MC; Danos O; Jiang H; Tan S Mol Ther Methods Clin Dev; 2017 Mar; 4():137-148. PubMed ID: 28344999 [TBL] [Abstract][Full Text] [Related]
7. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus. Antoniani C; Meneghini V; Lattanzi A; Felix T; Romano O; Magrin E; Weber L; Pavani G; El Hoss S; Kurita R; Nakamura Y; Cradick TJ; Lundberg AS; Porteus M; Amendola M; El Nemer W; Cavazzana M; Mavilio F; Miccio A Blood; 2018 Apr; 131(17):1960-1973. PubMed ID: 29519807 [TBL] [Abstract][Full Text] [Related]
8. Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia. Ma SP; Gao XX; Zhou GQ; Zhang HK; Yang JM; Wang WJ; Song XM; Chen HY; Lu DR Gene; 2022 Apr; 820():146289. PubMed ID: 35143940 [TBL] [Abstract][Full Text] [Related]
10. Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Buch T; Karimipoor M Data Brief; 2020 Feb; 28():104974. PubMed ID: 31890812 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia. Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses. Frati G; Brusson M; Sartre G; Mlayah B; Felix T; Chalumeau A; Antoniou P; Hardouin G; Concordet JP; Romano O; Turchiano G; Miccio A Mol Ther; 2024 Dec; 32(12):4337-4352. PubMed ID: 39044427 [TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 Editing of the Sharma A; Boelens JJ; Cancio M; Hankins JS; Bhad P; Azizy M; Lewandowski A; Zhao X; Chitnis S; Peddinti R; Zheng Y; Kapoor N; Ciceri F; Maclachlan T; Yang Y; Liu Y; Yuan J; Naumann U; Yu VWC; Stevenson SC; De Vita S; LaBelle JL N Engl J Med; 2023 Aug; 389(9):820-832. PubMed ID: 37646679 [TBL] [Abstract][Full Text] [Related]
15. Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells. Pavani G; Fabiano A; Laurent M; Amor F; Cantelli E; Chalumeau A; Maule G; Tachtsidi A; Concordet JP; Cereseto A; Mavilio F; Ferrari G; Miccio A; Amendola M Blood Adv; 2021 Mar; 5(5):1137-1153. PubMed ID: 33635334 [TBL] [Abstract][Full Text] [Related]
16. LIN28B-mediated expression of fetal hemoglobin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo. Lee YT; de Vasconcellos JF; Yuan J; Byrnes C; Noh SJ; Meier ER; Kim KS; Rabel A; Kaushal M; Muljo SA; Miller JL Blood; 2013 Aug; 122(6):1034-41. PubMed ID: 23798711 [TBL] [Abstract][Full Text] [Related]
17. Potent and uniform fetal hemoglobin induction via base editing. Mayuranathan T; Newby GA; Feng R; Yao Y; Mayberry KD; Lazzarotto CR; Li Y; Levine RM; Nimmagadda N; Dempsey E; Kang G; Porter SN; Doerfler PA; Zhang J; Jang Y; Chen J; Bell HW; Crossley M; Bhoopalan SV; Sharma A; Tisdale JF; Pruett-Miller SM; Cheng Y; Tsai SQ; Liu DR; Weiss MJ; Yen JS Nat Genet; 2023 Jul; 55(7):1210-1220. PubMed ID: 37400614 [TBL] [Abstract][Full Text] [Related]
18. Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression. Rajendiran V; Devaraju N; Haddad M; Ravi NS; Panigrahi L; Paul J; Gopalakrishnan C; Wyman S; Ariudainambi K; Mahalingam G; Periyasami Y; Prasad K; George A; Sukumaran D; Gopinathan S; Pai AA; Nakamura Y; Balasubramanian P; Ramalingam R; Thangavel S; Velayudhan SR; Corn JE; Mackay JP; Marepally S; Srivastava A; Crossley M; Mohankumar KM Mol Ther; 2024 Mar; 32(3):663-677. PubMed ID: 38273654 [TBL] [Abstract][Full Text] [Related]